Skip to main content

Table 2 Vaccine and control groups used during vaccination of mice

From: Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis

Vaccine and control groups (n: 11) Dose
Prime dose (day 0) Boost dose (day 21)
PBS 100 μl PBS / i.p. 100 μl PBS / i.p.
Montanide ISA 50 V 100 μl Montanide (+) 100 μl PBS 100 μl Montanide (+) 100 μl PBS
Hexavalent recombinant protein mixture Contains 6 different recombinant proteins [rH2 (+) rA4 (+) rE4 (+) rD6 (+) rE6 (+) rH6] in PBS. The amount of each protein is 20 μg in 200 μl PBS. Contains 6 different recombinant proteins [rH2 (+) rA4 (+) rE4 (+) rD6 (+) rE6 (+) rH6] in PBS. The amount of each protein is 20 μg in 200 μl PBS.
Hexavalent recombinant protein mixture (+) Montanide ISA 50 V Contains 6 different recombinant proteins [rH2 (+) rA4 (+) rE4 (+) rD6 (+) rE6 (+) rH6] in PBS. The amount of each protein is 20 μg in 100 μl PBS (+) 100 μl Montanide ISA 50 V Contains 6 different recombinant proteins [rH2 (+) rA4 (+) rE4 (+) rD6 (+) rE6 (+) rH6] in PBS. The amount of each protein is 20 μg in 100 μl PBS (+) 100 μl Montanide ISA 50 V